ストックスクリーナーアプリを入手
23.17
4.23%
0.9399
プレマーケット:
22.40
-0.7699
-3.32%
前日終値:
$22.23
開ける：
$22.28
24時間の取引高:
2,832
Relative Volume:
0.13
時価総額：
$51.38M
収益：
$5.02M
当期純損益:
$-18.31M
株価収益率:
-5.1148
EPS:
-4.53
ネットキャッシュフロー:
$-23.40M
1週間 パフォーマンス:
+17.79%
1か月 パフォーマンス:
+33.54%
6か月 パフォーマンス:
+56.98%
1年 パフォーマンス:
-14.07%
1日の値動き範囲:
$22.28
$23.20
1週間の範囲:
$18.89
$23.20
52週間の値動き範囲:
$12.12
$29.19
Vtv Therapeutics Inc Stock (VTVT) Company Profile
VTVT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
VTVT
Vtv Therapeutics Inc
|
23.17 | 51.38M | 5.02M | -18.31M | -23.40M | -4.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
496.49 | 122.76B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
610.86 | 61.38B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
620.97 | 36.37B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
254.85 | 30.12B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
249.46 | 24.70B | 3.81B | -644.79M | -669.77M | -6.24 |
Vtv Therapeutics Inc Stock (VTVT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2019-05-30 | 開始されました | H.C. Wainwright | Buy |
| 2018-04-10 | ダウングレード | Stifel | Buy → Hold |
| 2018-03-08 | 開始されました | ROTH Capital | Buy |
| 2018-02-08 | 開始されました | Northland Capital | Outperform |
| 2016-09-26 | 開始されました | H.C. Wainwright | Buy |
| 2015-09-04 | 開始されました | Canaccord Genuity | Buy |
| 2015-08-24 | 開始されました | Piper Jaffray | Overweight |
| 2015-08-24 | 開始されました | Stifel | Buy |
すべてを表示
Vtv Therapeutics Inc (VTVT) 最新ニュース
vTv Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:VTVT - Benzinga
vTv Therapeutics (NASDAQ:VTVT) Coverage Initiated at StockNews.com - Defense World
vTv Therapeutics Appoints Barry Brown as Interim CFO - MSN
vTv Therapeutics (NASDAQ:VTVT) Coverage Initiated at HC Wainwright - Defense World
Q1 Earnings Forecast for VTVT Issued By HC Wainwright - Defense World
HC Wainwright Initiates vTv Therapeutics With Buy Rating, $36 Price Target - MarketScreener
This Couchbase Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga
HC Wainwright & Co. Initiates Coverage of vTv Therapeutics (VTVT) with Buy Recommendation - Nasdaq
H.C. Wainwright sets $36 target for vTv Therapeutics stock By Investing.com - Investing.com Canada
H.C. Wainwright sets $36 target for vTv Therapeutics stock - Investing.com
(VTVT) Trading Advice - news.stocktradersdaily.com
vTv Therapeutics (NASDAQ:VTVT) Now Covered by StockNews.com - Defense World
(VTVT) Trading Signals - news.stocktradersdaily.com
vTv Therapeutics Inc Reports Q4 2024 EPS of -$0.55, Beating Esti - GuruFocus.com
vTv Therapeutics Announces 2024 Fourth Quarter and Full Year Financial Results and Provides Corporate Update - GlobeNewswire
The Zacks Analyst Blog Highlights Sarepta Therapeutics, Incyte, Gilead Sciences and VTv Therapeutics - Nasdaq
VTv Therapeutics: Q4 Earnings Snapshot - CTPost
vTv Therapeutics: A New Dawn for Diabetes Treatment? - AInvest
VTv Therapeutics: Q4 Earnings Snapshot -March 20, 2025 at 06:02 pm EDT - Marketscreener.com
vTv Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
FDA Greenlights vTv Diabetes Drug Trial as Cash Reserves Triple to $36.7M - StockTitan
vTv Therapeutics Inc. (VTVT) reports earnings - Quartz
Why Celsius Holdings Stock Popped This Week - The Globe and Mail
Biotech Stock Roundup: Patient Death Hits SRPT, INCY Study Data & More - Zacks Investment Research
Short Interest in vTv Therapeutics Inc. (NASDAQ:VTVT) Decreases By 13.6% - Defense World
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Biotech Alert: Searches spiking for these stocks today - TipRanks
StockNews.com Begins Coverage on vTv Therapeutics (NASDAQ:VTVT) - Defense World
vTv Therapeutics Soars 43% as FDA Lifts Clinical Hold on Diabetes Drug Trial - GuruFocus.com
Healthcare Up as Traders Rotate to Less Inflation-Sensitive Sectors -- Health Care Roundup - MarketScreener
Sector Update: Health Care Stocks Rise Late Afternoon - TradingView
Sector Update: Health Care -March 17, 2025 at 03:39 pm EDT - Marketscreener.com
FDA Lifts Clinical Hold On vTv Therapeutics' Phase 3 Diabetes Trial, Stock Surges - Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
FDA Lifts Clinical Hold, vTv Therapeutics (VTVT) Stock Surges - Stocks Telegraph
vTv Therapeutics up after FDA lifts clinical hold on its oral diabetes treatment study - Seeking Alpha
vTv Therapeutics resumes phase 3 diabetes trial By Investing.com - Investing.com Australia
VTv Therapeutics Says FDA Lifted Clinical Hold On Cadisegliatin Program For Diabetes - Nasdaq
vTv Therapeutics stock surges on FDA update By Investing.com - Investing.com Canada
Vtv Therapeutics Says FDA Lifts Clinical Hold on Cadisegliatin Program for Diabetes; Shares Up Pre-Bell - Marketscreener.com
vTv Therapeutics stock surges on FDA update - Investing.com
vTv Therapeutics resumes phase 3 diabetes trial - Investing.com
vTv Therapeutics Announces Resumption of CATT1 Phase 3 Trial for Cadisegliatin as Potential First Oral Adjunct Therapy for Type 1 Diabetes - Nasdaq
vTv Therapeutics Announces FDA has Lifted Clinical Hold on Cadisegliatin Program for Diabetes - The Manila Times
FDA Green Light: vTv's Revolutionary Oral Diabetes Drug Back on Track with Faster Timeline - StockTitan
3 Quality Compounders on Our Buy List - The Globe and Mail
Vtv Therapeutics Inc (VTVT) 財務データ
収益
当期純利益
現金流量
EPS
0.19%
大文字化:
|
ボリューム (24 時間):